Rafael Martínez

869 total citations
16 papers, 428 citations indexed

About

Rafael Martínez is a scholar working on Hematology, Molecular Biology and Oncology. According to data from OpenAlex, Rafael Martínez has authored 16 papers receiving a total of 428 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Hematology, 8 papers in Molecular Biology and 7 papers in Oncology. Recurrent topics in Rafael Martínez's work include Multiple Myeloma Research and Treatments (10 papers), Peptidase Inhibition and Analysis (5 papers) and Chronic Lymphocytic Leukemia Research (4 papers). Rafael Martínez is often cited by papers focused on Multiple Myeloma Research and Treatments (10 papers), Peptidase Inhibition and Analysis (5 papers) and Chronic Lymphocytic Leukemia Research (4 papers). Rafael Martínez collaborates with scholars based in Spain, Chile and Japan. Rafael Martínez's co-authors include Juan José Lahuerta, Jesús F. San Miguel, María José Terol, Felipe de Arriba, Laura Rosiñol, María‐Victoria Mateos, Josep‐María Ribera, María‐Belén Vídriales, Joan Bladé and Norma C. Gutiérrez and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Clinical Cancer Research.

In The Last Decade

Rafael Martínez

16 papers receiving 418 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Rafael Martínez Spain 8 252 173 168 123 122 16 428
Τατιάνα Τζένου Greece 12 200 0.8× 123 0.7× 179 1.1× 145 1.2× 128 1.0× 26 394
Alessia Tabarrini Italy 8 228 0.9× 93 0.5× 209 1.2× 133 1.1× 115 0.9× 9 493
Mark Juckett United States 11 264 1.0× 161 0.9× 182 1.1× 120 1.0× 116 1.0× 16 521
Dolores Caballero Spain 9 305 1.2× 123 0.7× 107 0.6× 124 1.0× 112 0.9× 17 428
Javier Pérez‐Calvo Spain 9 107 0.4× 169 1.0× 140 0.8× 85 0.7× 84 0.7× 16 398
Alex Freire Sandes Brazil 11 201 0.8× 92 0.5× 76 0.5× 162 1.3× 117 1.0× 35 415
M.V. Mateos Spain 9 358 1.4× 286 1.7× 269 1.6× 79 0.6× 132 1.1× 15 557
M. P. A. Lyttelton United Kingdom 10 157 0.6× 144 0.8× 81 0.5× 151 1.2× 154 1.3× 13 401
Erminia Rinaldi Italy 5 139 0.6× 194 1.1× 98 0.6× 77 0.6× 73 0.6× 9 338
Peter Forsyth United Kingdom 7 130 0.5× 103 0.6× 104 0.6× 136 1.1× 152 1.2× 14 391

Countries citing papers authored by Rafael Martínez

Since Specialization
Citations

This map shows the geographic impact of Rafael Martínez's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rafael Martínez with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rafael Martínez more than expected).

Fields of papers citing papers by Rafael Martínez

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rafael Martínez. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rafael Martínez. The network helps show where Rafael Martínez may publish in the future.

Co-authorship network of co-authors of Rafael Martínez

This figure shows the co-authorship network connecting the top 25 collaborators of Rafael Martínez. A scholar is included among the top collaborators of Rafael Martínez based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rafael Martínez. Rafael Martínez is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Nieto, Jorge Martínez, et al.. (2019). Characterization of deletional and non-deletional alpha globin variants in a large cohort from Spain between 2009 and 2014. Annals of Hematology. 98(7). 1537–1545. 6 indexed citations
2.
Paiva, Bruno, Noemí Puig, María‐Teresa Cedena, et al.. (2015). Prognostic Value of Immune Profiling Multiple Myeloma Patients during Minimal Residual Disease Monitoring in the Pethema/GEM2010MAS65 Study. Blood. 126(23). 721–721. 49 indexed citations
3.
Paiva, Bruno, Noemí Puig, María‐Teresa Cedena, et al.. (2015). Prognostic Value of Antigen Expression in Multiple Myeloma (MM): A Large GEM/Pethema Study Based in Four Consecutive Clinical Trials. Blood. 126(23). 19–19. 4 indexed citations
4.
Paiva, Bruno, María‐Teresa Cedena, Noemí Puig, et al.. (2015). The Relevance of Minimal Residual Disease (MRD) Monitoring in Elderly Multiple Myeloma (MM) Patients. Blood. 126(23). 4181–4181. 1 indexed citations
5.
6.
Mateos, María‐Victoria, Albert Oriol, Laura Rosiñol, et al.. (2013). Phase 2 Study Of Bendamustine, Bortezomib (Velcade) and Prednisone (BVP) For Newly Diagnosed Multiple Myeloma (MM). Blood. 122(21). 2155–2155. 1 indexed citations
7.
Martínez‐López, Joaquín, Ramón García‐Sánz, François Pépin, et al.. (2013). Prognostic value of deep sequencing method for minimal residual disease (MRD) detection in multiple myeloma.. Journal of Clinical Oncology. 31(15_suppl). 8511–8511. 2 indexed citations
8.
Rivero, Ana, Inmaculada Rapado, José Francisco Tomás, et al.. (2010). Relationship between deoxycytidine kinase (DCK) genotypic variants and fludarabine toxicity in patients with follicular lymphoma. Leukemia Research. 35(4). 431–437. 4 indexed citations
9.
Urrutia, Julio, et al.. (2010). Cultured autologous bone marrow stem cells inhibit bony fusion in a rabbit model of posterolateral lumbar fusion with autologous bone graft. Journal of Clinical Neuroscience. 17(4). 481–485. 11 indexed citations
10.
Sánchez‐Espiridión, Beatriz, Abel Sánchez‐Aguilera, Carlos Montalbán, et al.. (2009). A TaqMan Low-Density Array to Predict Outcome in Advanced Hodgkin's Lymphoma Using Paraffin-Embedded Samples. Clinical Cancer Research. 15(4). 1367–1375. 27 indexed citations
11.
Martínez‐López, Joaquín, Joaquín Martínez‐López, Ana Rivero, et al.. (2009). Influence ofMBL-2mutations in the infection risk of patients with follicular lymphoma treated with rituximab, fludarabine, and cyclophosphamide. Leukemia & lymphoma. 50(8). 1283–1289. 4 indexed citations
12.
13.
14.
Mateo, Gema, María-Ángeles Montalbán, María‐Belén Vídriales, et al.. (2008). Prognostic Value of Immunophenotyping in Multiple Myeloma: A Study by the PETHEMA/GEM Cooperative Study Groups on Patients Uniformly Treated With High-Dose Therapy. Journal of Clinical Oncology. 26(16). 2737–2744. 150 indexed citations
15.
Carreras, Enric, Laura Rosiñol, María José Terol, et al.. (2007). Veno-Occlusive Disease of the Liver after High-Dose Cytoreductive Therapy with Busulfan and Melphalan for Autologous Blood Stem Cell Transplantation in Multiple Myeloma Patients. Biology of Blood and Marrow Transplantation. 13(12). 1448–1454. 60 indexed citations
16.
Montalbán, Carlos, Juan F. Garcı́a, Víctor Abraira, et al.. (2004). Influence of Biologic Markers on the Outcome of Hodgkin's Lymphoma: A Study by the Spanish Hodgkin’s Lymphoma Study Group. Journal of Clinical Oncology. 22(9). 1664–1673. 54 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Τατιάνα Τζένου Breakdown of academic impact, for papers by Alessia Tabarrini Breakdown of academic impact, for papers by Mark Juckett Breakdown of academic impact, for papers by Dolores Caballero Breakdown of academic impact, for papers by Javier Pérez‐Calvo Breakdown of academic impact, for papers by Alex Freire Sandes Breakdown of academic impact, for papers by M.V. Mateos Breakdown of academic impact, for papers by M. P. A. Lyttelton Breakdown of academic impact, for papers by Erminia Rinaldi Breakdown of academic impact, for papers by Peter Forsyth
Rankless by CCL
2026